CARUSO, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 425
EU - Europa 105
AS - Asia 43
Totale 573
Nazione #
US - Stati Uniti d'America 424
IT - Italia 41
SE - Svezia 38
CN - Cina 14
IN - India 13
SG - Singapore 12
GB - Regno Unito 10
DE - Germania 6
FR - Francia 5
NL - Olanda 4
LB - Libano 2
PH - Filippine 2
CA - Canada 1
FI - Finlandia 1
Totale 573
Città #
Chandler 75
Fairfield 49
Nyköping 38
Ashburn 27
Woodbridge 27
Seattle 22
Cambridge 20
Wilmington 18
Houston 16
Lawrence 14
Hyderabad 12
Bari 11
Redwood City 11
Roxbury 11
San Diego 6
Des Moines 5
Inglewood 5
Princeton 5
Berlin 4
Dearborn 4
New York 4
Redmond 4
Rome 4
Singapore 4
Ann Arbor 3
Beijing 3
Nanjing 3
Naples 3
Paris 3
Brighton 2
Catania 2
Jacksonville 2
Kunming 2
Lecce 2
London 2
Milan 2
Southwark 2
Washington 2
Acton 1
Altamura 1
Amsterdam 1
Bromley 1
Centrale 1
Changsha 1
Chicago 1
Edinburgh 1
Elmira 1
Grafing 1
Guiyang 1
Hangzhou 1
Hefei 1
Kilburn 1
Lianyun 1
Los Angeles 1
Nanchang 1
Ottawa 1
Pune 1
Rockville 1
Totale 449
Nome #
Diabetes and cancer: pathophysiological fundamentals of a 'dangerous affair' 101
Heterogeneity and Similarities in GLP-1 Receptor Agonist Cardiovascular Outcomes Trials 96
Thyroid and shoulder diseases: the bases of a linked channel 76
Commentary: Glucose control: Not just a bystander in GLP-1RA-mediated cardiovascular protection 41
Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetes 32
The diabetic lung: An easy target for SARS-CoV-2? 31
Diabetes in the Time of COVID-19: A Twitter-Based Sentiment Analysis 30
Differential indication for SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with established atherosclerotic heart disease or at risk for congestive heart failure 28
Titratable fixed-ratio combination of insulin glargine plus lixisenatide: A simplified approach to glycemic control in type 2 diabetes mellitus 27
Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies 26
Role of glucose-lowering medications in erectile dysfunction 25
GLP-1 Receptor Agonists for Cardiovascular Protection: A Matter of Time 24
Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis 21
SGLT-2 inhibitors as cardio-renal protective agents 20
Glucagon in type 2 diabetes: Friend or foe? 12
Sodium-glucose co-transporter-2 inhibitors and protection from cardiovascular death: Is it all about heart failure? 11
Pharmacological modulation of adaptive thermogenesis: new clues for obesity management? 7
Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta-analysis 6
Diabetic foot: clinical approach 5
New insights into the treatment of non-healing diabetic foot ulcers 3
Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study 1
Totale 623
Categoria #
all - tutte 4.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.727


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202086 9 1 1 9 6 9 14 9 6 11 9 2
2020/2021112 1 3 0 7 28 7 22 13 11 10 9 1
2021/202290 7 0 1 3 0 7 2 4 17 19 10 20
2022/2023190 16 35 16 14 10 26 8 22 28 0 9 6
2023/202492 15 22 6 10 18 12 1 2 0 2 1 3
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 623